A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept ...

A Business School report highlights the stadium's significant role in driving economic activity in Auckland. The study ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with ...

Moscow 2030 forum was visited by more than 14 million Moscow residents and visitors to the city. The news was reported by Sergei Sobyanin in a post on ...

To put some numbers, and this is not exact science, but just taking it off what's being reported ... Let's dig a little bit further into the flows on Slide 10. So on the top left-hand side here, we ...

NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other neurologic disorders, announced its second ...

Creative Global Technology Holdings Limited (Nasdaq: CGTL) (the “Company”, “we”, “our”, “us” or “CGTL”), a company which ...

DelveInsight's NF-κB Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The ParkLands Foundation received nearly $81,000 through the Illinois Natural Areas Stewardship Grant program.

Nordic corporate bank SEB Group has published the latest edition of its Sustainable Finance Outlook, confirming that the ...

With superior reactivity and stability, nanocatalysts are transforming catalytic processes, driving advancements in green ...